Lyell Immunopharma, Inc. employees and revenue per employee

LYEL · Biotechnology · $352M market cap

Lyell Immunopharma, Inc. had 161 employees at the end of fiscal Dec 2025, down 46.3% from a year earlier. Revenue for the year was $36,000, down 41.0% from a year earlier, or $224 per employee. Revenue fell, and headcount fell or held flat with it.

Employees

161

-46.3% YoY

Revenue

$36,000

-41.0% YoY

Revenue / employee

$224

Peer median $457K

Rank in industry

109 of 110

Biotechnology

Open roles

5

31 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2021
0429859'21'22'23'24'25Revenue 0Staff 74

Hover a year for the numbers.

LYEL employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025161$36,000$224-46.3%-41.0%
Dec 2024300$61,000$203+33.9%-53.1%
Dec 2023224$130,000$1K-18.2%-99.8%
Dec 2022274$84.7M$309K+25.1%+695.1%
Dec 2021219$10.7M$49K——

Open roles on its job board: 5 (31 per 1,000 staff, against its latest annual headcount), as of 2026-11-16. Tracked since 2026-11-09. No 90 day change yet.

Employees, last six fiscal years
219'21274'22224'23300'24161'25
Revenue per employee, last six fiscal years
$49K'21$309K'22$1K'23$203'24$224'25

Lyell Immunopharma, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
STTK
Shattuck Labs, Inc.
40$1.0M$25KContracting
DNTH
Dianthus Therapeutics, Inc.
92$2.0M$22KHiring into decline
ABSI
Absci Corporation
140$2.8M$20KContracting
INBX
Inhibrx Biosciences Inc.
109$1.3M$12KLeaner
NGNE
Neurogene Inc.
107$925,000$9K—
CLDX
Celldex Therapeutics, Inc.
198$1.5M$8KHiring into decline
ARTV
Artiva Biotherapeutics, Inc.
89$251,000$3K—
AVTX
Avalo Therapeutics, Inc.
33$59,000$2KHiring into decline
LYEL
Lyell Immunopharma, Inc.
161$36,000$224Contracting
Every Healthcare company

Questions about Lyell Immunopharma, Inc.

How many employees does Lyell Immunopharma, Inc. have?
Lyell Immunopharma, Inc. reported 161 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 12, 2026. That is down 46.3% from a year earlier.
What is Lyell Immunopharma, Inc.'s revenue per employee?
Lyell Immunopharma, Inc. brought in $36,000 of revenue in fiscal Dec 2025, which is $224 per employee. That ranks 109 of 110 companies we track in Biotechnology, where the median is $457K.
Is Lyell Immunopharma, Inc. hiring?
Lyell Immunopharma, Inc.'s public job board listed 5 open roles on November 16, 2026, about 31 per 1,000 staff.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare LYEL with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Lyell Immunopharma, Inc.'s annual reports (Form 10-K), latest filed March 12, 2026. This is data, not a recommendation to buy or sell LYEL.